We provide evidence that NMD inhibition stabilizes the p53β and γ isoforms and restores p53 activity in not only p53-mutant cancer cells but also in cancer cells expressing WT p53 but are p53 deficient because of overexpression of its negative regulator MDM2. This evidence concerns the gene MDM2 and cancer.